Total Payments
$1,705
2024 Payments
$135.27
Companies
15
Transactions
44
Medicare Patients
2,087
Medicare Billing
$231,113
Payment Breakdown by Category
Food & Beverage$1,176 (69.0%)
Education$528.79 (31.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,176 | 37 | 69.0% |
| Education | $528.79 | 7 | 31.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $630.30 | 8 | $0 (2022) |
| Daiichi Sankyo Inc. | $352.29 | 9 | $0 (2023) |
| Sirtex Medical Inc | $145.38 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $133.32 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $116.80 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $93.96 | 6 | $0 (2018) |
| GlaxoSmithKline, LLC. | $73.43 | 5 | $0 (2024) |
| Lilly USA, LLC | $40.95 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $25.60 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $20.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.27 | 2 | AstraZeneca Pharmaceuticals LP ($120.29) |
| 2023 | $218.56 | 5 | Sirtex Medical Inc ($145.38) |
| 2022 | $26.78 | 2 | Amgen Inc. ($14.53) |
| 2021 | $622.84 | 11 | Amgen Inc. ($300.88) |
| 2020 | $228.84 | 4 | Amgen Inc. ($199.94) |
| 2019 | $128.17 | 3 | Novartis Pharmaceuticals Corporation ($116.80) |
| 2018 | $267.84 | 13 | Amgen Inc. ($114.95) |
| 2017 | $76.20 | 4 | E.R. Squibb & Sons, L.L.C. ($35.38) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $120.29 | General |
| 04/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $145.38 | General |
| Category: Interventional Oncology | ||||||
| 03/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $26.98 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Oncology | ||||||
| 12/02/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $123.03 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $110.88 | General |
| Category: Oncology | ||||||
| 09/08/2021 | Amgen Inc. | — | Education | In-kind items and services | $95.00 | General |
| 08/25/2021 | Amgen Inc. | — | Education | In-kind items and services | $95.00 | General |
| 08/16/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $115.81 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/09/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2020 | Amgen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 06/08/2020 | Amgen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 03/10/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 01/21/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Oncology | ||||||
| 11/19/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 471 | 671 | $212,450 | $51,941 |
| 2022 | 9 | 448 | 660 | $202,700 | $48,925 |
| 2021 | 7 | 559 | 846 | $265,840 | $64,430 |
| 2020 | 8 | 609 | 975 | $288,920 | $65,817 |
Total Patients
2,087
Total Services
3,152
Medicare Billing
$231,113
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 218 | 330 | $103,950 | $25,234 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 73 | $34,310 | $8,530 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 91 | 140 | $30,100 | $7,444 | 24.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 31 | $13,330 | $3,338 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $11,210 | $2,847 | 25.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 31 | $7,130 | $2,098 | 29.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 23 | $6,900 | $1,242 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $3,240 | $850.08 | 26.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $2,280 | $358.08 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 235 | 357 | $112,815 | $26,047 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 82 | 141 | $30,385 | $7,291 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 54 | $25,425 | $6,459 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $10,030 | $2,701 | 26.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 35 | $8,050 | $2,138 | 26.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $7,310 | $1,968 | 26.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $4,480 | $1,202 | 26.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 11 | 12 | $2,580 | $687.94 | 26.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,625 | $430.55 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 264 | 431 | $139,500 | $32,672 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 126 | 209 | $45,375 | $11,426 | 25.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 45 | 50 | $23,905 | $5,944 | 24.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 31 | 31 | $18,560 | $4,870 | 26.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 38 | 39 | $17,505 | $4,451 | 25.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 51 | $12,020 | $3,185 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $6,585 | $1,250 | 19.0% |
About Dr. Yadyra Rivera, M.D
Dr. Yadyra Rivera, M.D is a Specialist healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346272002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yadyra Rivera, M.D has received a total of $1,705 in payments from pharmaceutical and medical device companies, with $135.27 received in 2024. These payments were reported across 44 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,176).
As a Medicare-enrolled provider, Rivera has provided services to 2,087 Medicare beneficiaries, totaling 3,152 services with total Medicare billing of $231,113. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Teaneck, NJ
- Active Since 07/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1346272002
Products in Payments
- Enhertu (Drug) $352.29
- SIR-Spheres Microspheres (Device) $145.38
- LUMAKRAS (Drug) $125.41
- KISQALI (Drug) $116.80
- TRELEGY ELLIPTA (Drug) $73.43
- OPDIVO (Biological) $45.69
- VERZENIO (Drug) $40.95
- EMPLICITI (Biological) $35.38
- KEYTRUDA (Biological) $25.60
- DARZALEX (Biological) $20.53
- OCTAGENATE (Biological) $20.29
- Kyprolis (Drug) $15.00
- XARELTO (Drug) $13.63
- LYNPARZA (Drug) $13.03
- SPRYCEL (Drug) $12.89
- Lenvima (Drug) $11.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Teaneck
Dr. Peter Hersh, M.d, M.D
Specialist — Payments: $72,201
Specialist $72,201
Adam Palance, Md, MD
Specialist — Payments: $11,766
Specialist $11,766
Dr. Ebrahim Issa
Specialist — Payments: $7,680
Specialist $7,680
Dr. Christopher Brown, M.d, M.D
Specialist — Payments: $5,561
Specialist $5,561
Philip Micale, M.d, M.D
Specialist — Payments: $4,402
Specialist $4,402
Dr. Payal Shah
Specialist — Payments: $3,938
Specialist $3,938